Literature DB >> 7802661

Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.

Y Fujinaga1, K Inoue, S Shimazaki, K Tomochika, K Tsuzuki, N Fujii, T Watanabe, T Ohyama, K Takeshi, K Inoue.   

Abstract

The 16S progenitor toxin of Clostridium botulinum type C is made up by conjugation of a neurotoxin with nontoxic components designated as nontoxic-nonHA and hemagglutinin (HA). The HA was found to be composed of subcomponents having 53, 33, 22-23, and 17 kDa molecular masses. Since we previously determined the whole nucleotide sequences of the genes for neurotoxin, nontoxic-nonHA, and HA-33, the cloning and nucleotide sequencing of the genes for the remaining HA subcomponents were performed. Two open reading frames coding for 16.7 kDa (HA-17) and 70.6 kDa proteins were identified. The N-terminal amino acid sequences of HA-53 and HA-22-23 indicated that the 70.6 kDa protein is split into 53 and the 22-23 kDa proteins after translation and that the 22-23 kDa protein consists of at least four proteins showing slightly different molecular weights.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7802661     DOI: 10.1006/bbrc.1994.2805

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Crystallization and preliminary X-ray analysis of the HA3 component of Clostridium botulinum type C progenitor toxin.

Authors:  Toshio Nakamura; Takashi Tonozuka; Mao Kotani; Kanae Obata; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

3.  Construction of "Toxin Complex" in a Mutant Serotype C Strain of Clostridium botulinum Harboring a Defective Neurotoxin Gene.

Authors:  Tomonori Suzuki; Thomas Nagano; Koichi Niwa; Masataka Uchino; Motohiro Tomizawa; Yoshimasa Sagane; Toshihiro Watanabe
Journal:  Curr Microbiol       Date:  2016-10-26       Impact factor: 2.188

4.  Purification, crystallization and preliminary X-ray analysis of an HA17-HA70 (HA2-HA3) complex from Clostridium botulinum type C progenitor toxin.

Authors:  Chikako Iwasa; Takashi Tonozuka; Masaya Shinoda; Yoshimasa Sagane; Koichi Niwa; Toshihiro Watanabe; Hiromi Yoshida; Shigehiro Kamitori; Toshifumi Takao; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

5.  Characterization of botulinum progenitor toxins by mass spectrometry.

Authors:  Harry B Hines; Frank Lebeda; Martha Hale; Ernst E Brueggemann
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

6.  Mining new crystal protein genes from Bacillus thuringiensis on the basis of mixed plasmid-enriched genome sequencing and a computational pipeline.

Authors:  Weixing Ye; Lei Zhu; Yingying Liu; Neil Crickmore; Donghai Peng; Lifang Ruan; Ming Sun
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

7.  Molecular composition of Clostridium botulinum type A progenitor toxins.

Authors:  K Inoue; Y Fujinaga; T Watanabe; T Ohyama; K Takeshi; K Moriishi; H Nakajima; K Inoue; K Oguma
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 8.  On the interaction of Clostridium perfringens enterotoxin with claudins.

Authors:  Anna Veshnyakova; Jonas Protze; Jan Rossa; Ingolf E Blasig; Gerd Krause; Joerg Piontek
Journal:  Toxins (Basel)       Date:  2010-06-08       Impact factor: 4.546

9.  IBPred: A sequence-based predictor for identifying ion binding protein in phage.

Authors:  Shi-Shi Yuan; Dong Gao; Xue-Qin Xie; Cai-Yi Ma; Wei Su; Zhao-Yue Zhang; Yan Zheng; Hui Ding
Journal:  Comput Struct Biotechnol J       Date:  2022-08-28       Impact factor: 6.155

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.